Janux Therapeutics (JANX) Return on Equity [ROE] (2021 - 2026)
Janux Therapeutics' Return on Equity [ROE] was -10.98% in Q2 2026, down 0.43 percentage points from -10.55% a year earlier but up 1.09 percentage points from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Janux Therapeutics came in at -11.48%, down 1.39 percentage points from FY2024.
- Return on Equity [ROE] shows a four-year change of +7.10 percentage points (FY2021 to FY2025).
- In earlier years, Return on Equity [ROE] was -10.09% in FY2024 (+7.44 pp), -17.53% in FY2023 (+0.83 pp), -18.36% in FY2022 (+0.22 pp) and -18.58% in FY2021.
- Quarterly Return on Equity [ROE] has moved between -22.18% (Q2 2023) and -5.49% (Q3 2021) over five years.
- Compared with a year earlier, Return on Equity [ROE] has declined for five straight quarters, with an average year-over-year change of +1.10 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 15.47 percentage points); the worst was Q3 2022 (a drop of 12.40 percentage points).
- Per Business Quant data, JANX's Return on Equity [ROE] in the three quarters before Q2 2026 was -12.06% (Q1 2026), -11.75% (Q4 2025) and -10.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Janux Therapeutics | 1.06 Bn | 1.06 Bn | - | -10.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.98% |
| Mar 31, 2026 | -12.06% |
| Dec 31, 2025 | -11.75% |
| Sep 30, 2025 | -10.36% |
| Jun 30, 2025 | -10.55% |
| Mar 31, 2025 | -7.64% |
| Dec 31, 2024 | -8.22% |
| Sep 30, 2024 | -9.22% |
| Jun 30, 2024 | -6.71% |
| Mar 31, 2024 | -11.12% |
| Dec 31, 2023 | -16.82% |
| Sep 30, 2023 | -19.31% |
| Jun 30, 2023 | -22.18% |
| Mar 31, 2023 | -21.24% |
| Dec 31, 2022 | -19.34% |
| Sep 30, 2022 | -17.89% |
| Jun 30, 2022 | -15.57% |
| Mar 31, 2022 | -12.13% |
| Dec 31, 2021 | -8.79% |
| Sep 30, 2021 | -5.49% |
API Access
Janux Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();